| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Chief Medical Officer | Common Stock | 44,000 | $607,200 | $13.80 | 02 Feb 2026 | Direct |
| Janux Therapeutics, Inc. | Chief Medical Officer | Stock option (right to buy) | 154,000 | 02 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | 02 Feb 2026 | 2 | $0 | 4 | Chief Medical Officer | 04 Feb 2026, 20:01 |
| JANX | Janux Therapeutics, Inc. | 26 Jan 2026 | 0 | $0 | 3 | Chief Medical Officer | 04 Feb 2026, 20:00 |